Early Control of PTH and FGF23 in Normophosphatemic CKD Patients: A New Target in CKD-MBD Therapy?

Background and objectives: Levels of parathyroid hormone (PTH) and the phosphaturic hormone FGF23, a fibroblast growth factor (FGF) family member, increase early in chronic kidney disease (CKD) before the occurrence of hyperphosphatemia. This short-term 6-wk dose titration study evaluated the effect...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Oliveira, Rodrigo B., Cancela, Ana L.E., Graciolli, Fabiana G., Dos Reis, Luciene M., Draibe, Sérgio A., Cuppari, Lilian, Carvalho, Aluizio B., Jorgetti, Vanda, Canziani, Maria E., Moysés, Rosa M.A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Nephrology 2010
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2827593/
https://ncbi.nlm.nih.gov/pubmed/19965540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.05420709
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller